KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments

Posted on Mar 02, 2021, 3 p.m.


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.


The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta-lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.  


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta-lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://www.worldhealth.net/news/antibiotic-tolerance-study-paves-way-new-treatments/


List of Articles
번호 제목 글쓴이 날짜 조회 수
390 [김대수 교수님] 액트노바, 카카오벤처스로부터 5억 규모 시드 투자 유치 "육안으로 진행되던 임상·비임상 분야 행동 실험 과정, 인공지능 영상처리 기술로 자동화" 생명과학과 2022.08.10 465
389 [김대수 교수님] 제약바이오협회, ‘KPBMA-MIT 생명과학 컨퍼런스’ 개최 생명과학과 2022.03.28 612
388 [김보람 박사님(서성배 교수님 연구실)] 2022년 국가연구개발 우수성과 100선 선정 file 생명과학과 2022.11.09 540
387 [김보람 박사님(서성배 교수님 연구실)] 한국뇌연구원 제2회 다한우수논문상 선정 생명과학과 2022.12.07 402
386 [김상규 교수님] 구글도 올라 탄 神으로 가는 길[과학을읽다] 생명과학과 2022.09.07 600
385 [김상규 교수님] 꽃향기, 이젠 눈으로 보세요!​ 생명과학과 2022.05.10 705
384 [김상규 교수님] 단일세포 RNA 시퀀싱을 통한 꽃향기 합성 유전자 발굴​ 생명과학과 2022.02.15 497
383 [김상규 교수님] 생명과학과의 낭만과학자 Eco Lab 대표 김사부(KAIST 유튜브) 생명과학과 2023.12.12 270
382 [김상규 교수님] 식물 유전자 비밀 푸는 김상규 카이스트 교수 생명과학과 2021.11.24 601
381 [김세윤, 양한슬 교수님] 장 조직의 항상성과 염증성 장염 회복의 핵심 효소 발견​ 생명과학과 2022.10.07 493
380 [김세윤, 이대엽 교수님] "후성유전 조절하는 핵심 분자기전 찾았다" 생명과학과 2022.06.02 798
379 [김세윤, 정원석, 손종우 교수님] 인공지능 기반 약물 가상 스크리닝 기술로 신규 항암 치료제 발굴 성공 생명과학과 2022.08.12 518
378 [김윤기 교수님] 새로운 단백질 번역기전 규명 file 생명과학과 2023.10.12 433
377 [김윤기 교수님] 저용량 고효율 RNA백신 개발 가능해지다​ 생명과학과 2023.10.24 275
376 [김윤기, 조원기 교수님] 비정상 단백질 처리에 관여하는 새로운 인자 발견 생명과학과 2023.10.12 246
375 [김은준 교수님] 대규모 한국인 자폐증 가족 유전체 연구를 통한 새로운 자폐 유전변이 최초 발견​ 생명과학과 2022.07.19 405
374 [김은준 교수님] 자폐 진단․ 치료 골든타임, 동물실험으로 확인 생명과학과 2022.09.27 379
373 [김재경 교수님] 포스코 사이언스 펠로십 선정​ 생명과학과 2023.10.18 284
372 [김진우 교수님, 민광욱 박사님] 왼쪽 눈이 본 것을 오른쪽 뇌가 알게 하라​ 생명과학과 2023.03.02 489
371 [김진우 교수님] 새로운 세포핵 단백질의 이동 루트 발견​ 생명과학과 2023.02.28 369
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 22 Next
/ 22